New Risk • Jun 27
New major risk - Revenue and earnings growth Earnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$93k). Market cap is less than US$10m (€7.00m market cap, or US$8.19m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Buy Or Sell Opportunity • May 27
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 24% to €2.20. The fair value is estimated to be €2.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 65% over the last 3 years. Meanwhile, the company became loss making. New Risk • Apr 30
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2023 fiscal period end). Revenue is less than US$1m. Market cap is less than US$10m (€5.29m market cap, or US$6.01m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Apr 23
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to €2.21, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in France. Total loss to shareholders of 45% over the past three years. Buy Or Sell Opportunity • Apr 23
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.8% to €2.21. The fair value is estimated to be €2.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €2.91, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 21x in the Chemicals industry in France. Total loss to shareholders of 27% over the past three years. Buy Or Sell Opportunity • Jan 15
Now 31% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.7% to €2.02. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%. Valuation Update With 7 Day Price Move • Jan 14
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to €2.35, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 44% over the past three years. New Risk • Jan 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.46m market cap, or US$4.62m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding). New Risk • Nov 22
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.43m market cap, or US$4.61m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding). New Risk • Nov 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€4.60m market cap, or US$4.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.1% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding). Buy Or Sell Opportunity • Aug 29
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to €2.28. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%. Buy Or Sell Opportunity • Aug 13
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to €2.34. The fair value is estimated to be €2.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%. New Risk • Jun 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€5.87m market cap, or US$6.31m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding). Tillkännagivande • May 26
Méthanor SCA, Annual General Meeting, Jun 28, 2024 Méthanor SCA, Annual General Meeting, Jun 28, 2024. Location: 24 rue de clichy, paris France New Risk • Apr 05
New major risk - Revenue and earnings growth Earnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€7.02m market cap, or US$7.61m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding). Buy Or Sell Opportunity • Mar 13
Now 21% overvalued Over the last 90 days, the stock has fallen 2.2% to €3.07. The fair value is estimated to be €2.55, however this is not to be taken as a sell recommendation but rather should be used as a guide only. New Risk • Jan 25
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (€80k revenue, or US$87k). Market cap is less than US$10m (€7.28m market cap, or US$7.94m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding). New Risk • Dec 11
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$86k). Market cap is less than US$10m (€6.38m market cap, or US$6.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results. Price Target Changed • Dec 08
Price target decreased by 7.9% to €5.69 Down from €6.18, the current price target is provided by 1 analyst. New target price is 81% above last closing price of €3.14. Stock is down 13% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.64 last year. Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €3.40, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 13x in the Chemicals industry in France. Total loss to shareholders of 28% over the past three years. New Risk • Oct 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$85k). Market cap is less than US$10m (€6.11m market cap, or US$6.48m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results. Upcoming Dividend • Jun 29
Upcoming dividend of €0.15 per share at 3.9% yield Eligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Trailing yield: 3.9%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (2.0%). Price Target Changed • May 09
Price target increased by 7.3% to €6.16 Up from €5.74, the current price target is provided by 1 analyst. New target price is 74% above last closing price of €3.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of €0.57 next year compared to a net loss per share of €0.43 last year. Tillkännagivande • Dec 23
An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million. An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million on December 21, 2022.
An unknown buyer completed the acquisition of portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) on December 21, 2022. Price Target Changed • Jan 03
Price target decreased to €5.35 Down from €5.85, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €4.10. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.11 last year. Valuation Update With 7 Day Price Move • Dec 27
Investor sentiment deteriorated over the past week After last week's 15% share price decline to €4.05, the stock trades at a trailing P/E ratio of 32.9x. Average trailing P/E is 18x in the Oil and Gas industry in France. Total loss to shareholders of 4.3% over the past three years. Upcoming Dividend • Jul 06
Upcoming dividend of €0.10 per share Eligible shareholders must have bought the stock before 13 July 2021. Payment date: 04 August 2021. Trailing yield: 2.0%. Lower than top quartile of French dividend payers (3.7%). Lower than average of industry peers (6.7%). Is New 90 Day High Low • Oct 26
New 90-day low: €4.90 The company is down 16% from its price of €5.80 on 28 July 2020. The French market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 12% over the same period. Is New 90 Day High Low • Oct 08
New 90-day low: €5.05 The company is down 18% from its price of €6.15 on 10 July 2020. The French market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 11% over the same period. Is New 90 Day High Low • Sep 23
New 90-day low: €5.20 The company is down 4.0% from its price of €5.40 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Oil and Gas industry, which is down 14% over the same period.